Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression
about
Megakaryocyte biology and related disordersEndopolyploidy in irradiated p53-deficient tumour cell lines: persistence of cell division activity in giant cells expressing Aurora-B kinasePhosphorylation of ribosomal protein S6 kinase 1 at Thr421/Ser424 and dephosphorylation at Thr389 regulates SP600125-induced polyploidization of megakaryocytic cell linesUpregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidyThe DNA-damage effector checkpoint kinase 1 is essential for chromosome segregation and cytokinesis.Direct visualization of the endomitotic cell cycle in living megakaryocytes: differential patterns in low and high ploidy cells.Mechanism of Aurora-B degradation and its dependency on intact KEN and A-boxes: identification of an aneuploidy-promoting propertyNew roles for cyclin E in megakaryocytic polyploidization.Differential requirements for survivin in hematopoietic cell development.The aurora kinases in cell cycle and leukemiaCytosolic carboxypeptidase CCP6 is required for megakaryopoiesis by modulating Mad2 polyglutamylationAurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation.Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myelomaRequirements for survivin in terminal differentiation of erythroid cells and maintenance of hematopoietic stem and progenitor cells.Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins.Survivin study: an update of "what is the next wave"?Survivin overexpression alone does not alter megakaryocyte ploidy nor interfere with erythroid/megakaryocytic lineage development in transgenic mice.Normal and malignant megakaryopoiesis.Survivin is not required for the endomitotic cell cycle of megakaryocytesDeregulated Aurora-B induced tetraploidy promotes tumorigenesis.Targeting of polo-like kinases and their cross talk with Aurora kinases--possible therapeutic strategies in human acute myeloid leukemia?Sumoylation of EKLF promotes transcriptional repression and is involved in inhibition of megakaryopoiesis.Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656.Conditional overexpression of transgenes in megakaryocytes and platelets in vivo.Survivin localization during endomitosis of high ploidy mouse megakaryocytes.Optimizing megakaryocyte polyploidization by targeting multiple pathways of cytokinesis.Increased dosage of Runx1/AML1 acts as a positive modulator of myeloid leukemogenesis in BXH2 mice.
P2860
Q24536140-80967E81-9B41-4571-8183-6813AD9D9C91Q24650663-2B22B091-2892-4011-96C3-6AE59EB36EF2Q28542559-52A1D17D-CD6E-4411-BBC0-3AFF11278AE9Q28576215-99EBB7E5-8ED5-4B53-ABA7-CCBCABA4AE1BQ30486781-89F2D580-3E03-4964-AD58-EE31DCC25A67Q30494274-D7AB3C36-6D82-47D2-B734-D5B5EE908DB4Q33836931-02D2F4F9-B473-4E43-9B2A-094B1171DE05Q33897984-2684877F-2214-4EF1-99C6-0D8D79D68CEAQ33913884-58D277E8-57FB-4750-BB82-74E5204B0C37Q34203062-6F5679D0-7716-4990-B192-351511DF2C01Q34533046-CEC5FD57-E37B-4BDB-A52C-8E48AA2D8358Q35220665-7061236C-A2AE-4FAF-AB35-DA2B656C9A00Q35848298-BDAE144B-7B1E-4164-958F-D1ABB8022C31Q36229508-AC38CBA9-4227-4AA9-B50C-28D6BDE810CEQ36332561-5B6AD9DF-8019-4938-953C-981661DF0031Q36430244-14F86EBA-09BA-48BE-B64B-2C653A1022B3Q36528762-A57BCD2A-A696-4AF4-B04C-8EC0F83E2D5AQ36909019-458835AB-23E1-43C0-B9A8-ECFE77EB2B86Q37262466-E2AD243C-815B-41FE-8810-C0BE56FD9D5BQ37280830-6B48EB76-FC4C-4D08-8275-E396DD109B68Q37994256-ED6BB115-8B31-4821-B282-BC9E4101FDFBQ40067452-F5573D7D-9C36-444C-914F-690699CE70B7Q40464481-A387ADD1-259E-4640-A305-72B57C9861CEQ42194316-22AE40EB-EA51-4043-BD84-CBDEB2AB7D61Q42412464-5393FDF9-FC9D-4FB6-96E2-04B82E005DB2Q53734886-17C3173D-5ACB-47BB-8D97-12625D8596A1Q53773428-F3F35B20-198E-4197-A7E9-01EE6E4D201B
P2860
Aberrant quantity and localization of Aurora-B/AIM-1 and survivin during megakaryocyte polyploidization and the consequences of Aurora-B/AIM-1-deregulated expression
description
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
im Januar 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/05/15)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/05/15)
@nl
наукова стаття, опублікована в травні 2004
@uk
مقالة علمية (نشرت في 15-5-2004)
@ar
name
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@ast
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@en
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@nl
type
label
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@ast
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@en
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@nl
prefLabel
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@ast
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@en
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@nl
P2093
P50
P1433
P1476
Aberrant quantity and localiza ...... B/AIM-1-deregulated expression
@en
P2093
Carl W Jackson
Guangyao Yu
Kazuo Todokoro
Masaaki Tatsuka
Paul Toselli
Ying Zhang
Yuka Nagata
P304
P356
10.1182/BLOOD-2003-09-3365
P407
P577
2004-01-29T00:00:00Z